
TSE:L
This summary was created by AI, based on 15 opinions in the last 12 months.
Loblaw Companies Ltd is viewed as a solid defensive investment, particularly due to its position as the largest grocery and pharmacy retailer in Canada. The company has been focusing on its private label offerings, which have shown strong margins, and Shoppers Drug Mart, its pharmacy division, is contributing positively to growth. Despite some concerns about the competitive landscape and inflationary pressures in the grocery sector, analysts note the company's ability to maintain profitability and generate significant free cash flow. Some experts suggest that while the stock has performed well recently, it is currently trading at a high valuation, which may prompt caution for potential investors. Overall, Loblaw is seen as a reliable choice in uncertain economic times, although some analysts lean towards alternative investments within the sector.
This is a recent addition to their portfolio. Loblaw runs some dominant banners in both grocery retailing and pharmacy. Have accelerated their organic growth with the purchase of Shoppers Drugmart. They have gained market share and shown margin improvement. We like what they are doing operationally and financially. Stock is trading at 14X earnings. The value of growth and consistency in this name is exceptional. (Analysts’ price target is $76.92)
Reasonable in terms of a longer term outlook. They sell products that everyone needs: food, and pharmaceuticals and beauty products through Shoppers Drug Mart. Good positions and locations in both those segments, which are critical for those types of businesses. Experienced operators. The industry is in transition regarding goods delivery and pickup. They have click and collect, and have introduced online delivery. Some headwinds with minimum wage, which they’re now overcoming. Earnings growth not that stellar. Going forward earnings should be in mid to high single digit range. Stock is reasonably priced at around $65, with a bit of a yield.
He recently bought this. Cash flow and earnings have ticked up, though the stock has been sidways the past few years. They've done well integrating Shopper's Drug Mart. They are massively buying back stock. Also done well growing No Frills, a growth opportunity. A safe, defensive name with room to grow. Pays a 1.8% dividend.
Lots of competition from well capitalized companies. Not really compelling form a technical point of view. Some of the reforms affecting the price of the generics drugs affect Shoppers Drug Mart that is owned by this company. There is also food inflation to deal with. Consumers staples in general is a sector that he doesn’t like. Margins are very thin.